← 返回列表 › SCI 期刊 › 医学 › Clin Transl Gastroenterol

Clinical and Translational Gastroenterology

Clin Transl Gastroenterol

ISSN 2155-384X
SCIE Q2 新锐3区 开放获取 医学
影响因子 2026
3.6
↑ 0.6
5年均分
3.519
5-Year IF
H 指数
26
H-Index
年发文量
143
Articles / Year
出刊频率
Continuously Published
Pub. Frequency
创刊年份
1977
Founded Year
出版商
Lippincott Williams & Wilkins
Publisher
出版国家
USA
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 3.7 个月
💰 版面费用
★★★★★
系统
暂无
官方APC $2,800 USD 约¥20,300
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类3区
胃肠肝病学
中科院2025年分区 传统体系
大类3区
医学Medicine
小类4区
胃肠肝病学
Scopus 指标
CiteScore
5.1
综合引用得分
SJR
1.138 Q1
SCImago Journal Rank
SNIP
0.986
Source Normalized Impact
JCI
0.71
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Clinical and Translational Gastroenterology (ISSN: 2155-384X) is a peer-reviewed, open-access journal published by Wolters Kluwer on behalf of the American College of Gastroenterology. The journal serves as a dedicated platform for the rapid dissemination of original research and clinical advances that bridge the gap between basic science and patient care in gastroenterology and hepatology. Its scope encompasses the full spectrum of digestive disorders, including but not limited to inflammatory bowel disease, colorectal cancer, pancreatic diseases, liver disease, functional gastrointestinal disorders, and gastrointestinal infections. The journal prioritizes translational research that directly informs clinical practice, as well as high-quality clinical trials, cohort studies, and meta-analyses. In addition to original articles, Clinical and Translational Gastroenterology publishes systematic reviews, narrative reviews, guidelines, and brief reports. The target audience comprises gastroenterologists, hepatologists, clinical investigators, and allied health professionals seeking timely, evidence-based findings to improve patient outcomes. A notable feature of the journal is its open-access model, ensuring that all articles are freely available to readers worldwide, which enhances the visibility and impact of published work. With a 2026 Impact Factor of 4.3960 and a JCR Quartile ranking of Q2, the journal occupies a strong mid-tier position in the field of gastroenterology and hepatology. It is recognized for its efficient peer-review process and commitment to publishing clinically relevant translational science, making it a respected venue for authors and a valuable resource for practitioners aiming to stay current with emerging therapeutic and diagnostic developments.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.